Zacks Investment Research on MSN
MMED's latest study supports the strength of 780G SmartGuard algorithm
MiniMed Group, Inc. MMED recently announced results from a new randomized crossover study showing that glycemic outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results